Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status

✍ Scribed by Gordon, M. S.; Matei, D.; Aghajanian, C.; Matulonis, U. A.; Brewer, M.; Fleming, G. F.; Hainsworth, J. D.; Garcia, A. A.; Pegram, M. D.; Schilder, R. J.; Cohn, D. E.; Roman, L.; Derynck, M. K.; Ng, K.; Lyons, B.; Allison, D. E.; Eberhard, D. A.; Pham, T. Q.; Dere, R. C.; Karlan, B. Y.

• Book ID: 125547810
• Publisher: American Society of Clinical Oncology
• Year: 2006
• Tongue: English
• Weight: 351 KB
• Volume: 24
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2005.05.4221